A federal official is defending new HHS interim rules against criticism that they favor insurers.
Experts say the success of the new pills hinge on whether high-risk patients will be able to get tested — and then treated — fast enough to make a difference.
The system faces immediate needs to retain workers during the pandemic amid long-term plans that may transform it.
With eligibility checks on Oregon Health Plan members expected to resume as soon as January, the state wants to slow down the process and increase outreach.
Doctors and members of Congress are arguing that the rule for implementing the No Surprises Act favors insurers and doesn’t follow the spirit of the legislation.
PhRMA regards drug price negotiation for Medicare as an existential threat to its business — potentially costing billions.
Sen. Kayse Jama and Rep. Pam Marsh are working on bills that will address extreme heat conditions.
Experts say teletherapy has proven to give positive results similar to those achieved through in-patient care.
Industry urges lawmakers to consider more incentives, such as student loan repayment, tuition assistance and child care stipends.
On Tuesday the Portland Public Schools board will hear a staff recommendation to delay a proposed student vaccine requirement for at least six months.